Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Spetzler

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic CancerHarshabad Singh, Joanne Xiu, Kevin S Kapner, et al.
JCO Precision Oncology|November 20, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid TumorsRouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, et al.
Nature Communications|March 25, 2018
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomesValeriy Domenyuk, Zoran Gatalica, Radhika Santhanam, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Oncotarget|August 13, 2025
Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assayValeriy Domenyuk, Kasey Benson, Peggy Carter, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Science (New York, N.Y.)|June 10, 2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T Le, Jennifer N Durham, Kellie N Smith, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort studyJingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic CancerHarshabad Singh, Joanne Xiu, Kevin S Kapner, et al.
JCO Precision Oncology|November 20, 2024
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid TumorsRouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, et al.
Nature Communications|March 25, 2018
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomesValeriy Domenyuk, Zoran Gatalica, Radhika Santhanam, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Oncotarget|August 13, 2025
Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assayValeriy Domenyuk, Kasey Benson, Peggy Carter, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket TrialPetros Grivas, Elena Garralda, Funda Meric-Bernstam, et al.
Science (New York, N.Y.)|June 10, 2017
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T Le, Jennifer N Durham, Kellie N Smith, et al.
Pageof 9